I never doubted Jeffrey for a single second after scanning his CV following his appointment. He’s excelled in his position thus far, and I’m genuinely excited to see where he can take the company in the coming years.
'Where do you see the sp over the next few months?'
Deos, this question is barely worth asking as it's so subjective in nature. I hope you don't take offence to me saying this, but the share price prediction should be the figure at which you, individually arrive at as a result of your due diligence and valuation of the company.
Just because I tell you that I believe the share price will be X or Y, it doesn't substantiate those figures in the real world, hence the postings on these boards should be taken with more than just a pinch of salt.
I hope you don't take offence to me expressing this, however skim reading your previous posts paints a stark picture of your approach to equity investing. You already testify to making significant losses on this share, don't let your emotional affiliation with this share lead to this becoming a recurring theme. Whilst the price of this share may increase significantly throughout the course of time, it should be your individual research, and that alone, which underpins your investment decisions.
If you're looking for some brilliant resources on valuation methodology, Aswath Damodaran has uploaded his entire course (ordinarily taught at NYU) for free on Youtube, which might be of use to you. It's many hours of viewing, however it'll provide you with a firm foundation on which to better ascertain the value of an equity.
Reviewing your previous posts, you claim to have sold at a 30k loss at £4.50. Just interested to know how you ended up with a £5.5 average? Did you buy back in shortly after materialising a loss?
Personally, I can’t see NCYT returning to its previous highs unless it’s relationship with the UK gov becomes more amicable, which, judging from the impending court case, is somewhat far fetched. Although cases are rising, the predominant age ranges affected are all from low risk groups, therefore hospitalisations are predicted to remain flat. At the NHS trust in which I currently work, hospitalisations are negligible, despite being one of the worst hit Acute Hospitals during both waves of the pandemic. Procurement have significantly increased accessibility to a more diverse range of tests from an ever expanding number of providers, with the sector becoming seemingly more squeezed due to heightened competition.
Without product diversification into non-covid markets, I struggle to see how Novacyt can maintain its relevance. As foreign markets become more self sufficient, I can see the avenues for making profits from covid diminishing significantly.
In terms of short term pricing, who knows, but keep in mind there is still a material risk that the SOA will be rejected and Amigo will therefore begin the insolvency process. This is the main inherent risk as far as I can see. I view this entire saga extremely similarly to CINE during the height of the Covid crisis. There was much material uncertainty about the future of the company, which at one point seemed like it would manifest as its complete demise; with the creditors stripping what they could and the shareholders nursing their wounds. Rather ironically, the share price at this point was 25pps. With their successful restructuring of debt and the assurance of continued operations, they very quickly rose in price and are currently sitting at 94pps (from highs of 120pps) at the time of typing this.
Back to Amigo. If the SOA is approved, I believe it could catalyse a similar change in sentiment towards the share. At this point, it's a complete guess. Of the people I've asked, most have said that they would agree to the SOA, based on the fact that even a small material gain in wealth is better than nothing at all. Of the aforementioned, however, none are previous customers of Amigo, therefore situationally it's difficult to generalise the results.
If a person had a particularly resentment towards Amigo, they may well feel inclined to reject the SOA out of disdain for the company itself. Revenge is a very visceral trait of being human, and I do believe there will be a number of people who exercise this option, as opposed to accepting the small goodwill gesture offered by Amigo. My confidence is rallied by the continued buying from institutions, however, if we're led to believe that the market is a level playing field (yeah, right), then they know no more than you and I about the current progress of the SOA.
Strap in for the ride, but only with money you wouldn't be too bitter to see lost in its entirety. Good luck all, I'll be strapped in with you on the 12th!
To put it succinctly: - Late April until May 10th is the window for online responses to the proposed SOA. - May 12th is the Creditors meeting where we should find out whether the scheme has passed the vote. - May 19th is the second court sitting (following the first sitting March 30th) where the final decision will be made.
In terms of the FCA, the board are still actively engaging with them, so I'm guessing news will flow later down the line, following the court ruling on the SOA.
Anybody remember around the same time a chap who went by the name fatbloke? He gambled his daughters wedding fund on AMGO and was down pretty heavily. Hope he made it though, he seemed like a really genuine individual, haven’t seen him posting here for a while, mind you.
With the antigen LFT seemingly (very nearly) signed off, what about our other revenue streams?
Do we anticipate any further orders of ABC-19, in light of the recent scrutiny of Abingdon? I personally think antibody testing is still relevant, however its prevalence and usefulness will prove itself in the latter stages of the pandemic (population surveillance / research epidemiology).
Anybody have a bullish predisposition on the UK RTC/ABC-19?
Stop being such a pessimist, this has quintuple rise written all over it! Furthermore, sources also suggest that Colin has agreed to don a kilt and perform a personal lap dance on each and every ODX investor, in lieu of future dividends (obviously).
RE: 75 Million pounds contact confirm.21 Jan 2021 21:14
A nuclear 63p or an open of £1? Dear god, I'm seriously hoping these comments were satire...
Why not throw all rational thought out of the window? My calculations indicate a £6 open tomorrow, based on a contract dated December and the repetitive basing of my head off a calculator. If Zengah wasn't too busy counting his losses on ARB, I'm sure he'd certify the literality of my predictions. DYOR.